Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Country:  U.S.A.
Treatment/Intervention:  nutritional therapy
Results 1-25 of 56 for your search:
Start Over
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 to 72
Trial IDs: CS001P3, NCI-2014-01668, 2010-019952-35, NCT01265849
OPT-821 with Vaccine Therapy and Beta-Glucan in Treating Younger Patients with High-Risk Neuroblastoma
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 21 and under
Trial IDs: 05-075, NCI-2009-01362, NCT00911560
Irinotecan Hydrochloride with or without Chinese Herbal Formulation PHY906 in Treating Patients with Metastatic Colorectal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 12-005, NCI-2016-00749, NCT00730158
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: IOM-HNC-201-IL, NCI-2015-01924, NCT01400620
Combination Chemotherapy, Bevacizumab, and Cholecalciferol in Treating Patients with Previously Untreated Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-436, NCI-2012-00662, NCT01516216
Ascorbic Acid, Gemcitabine Hydrochloride, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 75
Trial IDs: 11D.365, NCI-2012-00340, 2008-52(1), NCT01555489
Curcumin in Reducing Fatigue in Patients with Chemotherapy-Treated Breast Cancer Undergoing Radiotherapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: WINSHIP2139-11, NCI-2014-02195, IRB00055328, NCT01740323
Carbohydrate-Restricted Diet in Treating Patients with Previously Treated Prostate Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 20 and over
Trial IDs: Pro00041857, NCI-2013-00581, 00041857, Amd020_Pro00041857, NCT01763944
Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients with Breast or Prostate Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 19 and over
Trial IDs: 0S-10-3, NCI-2013-00414, HS-11-00231, NCT01802346
Calcitriol before Surgery in Preventing Calcium Loss in Patients Undergoing Thyroidectomy
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: TC-P2-CALCITRIOL, NCI-2014-00962, NCT01868750
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients with Localized Prostate Cancer Undergoing Active Surveillance
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 21 and over
Trial IDs: CO11378, NCI-2014-00695, N01-CN-2012-00033, UWI2013-00-01, NCT02095145
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
Status: Active
Phase: Phase II
Type: Prevention
Age: 50 to 80
Trial IDs: 13-000432, NCI-2014-01257, 13-000432-AM-00004, NCT02176902
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GHNSCLC-2 001, NCI-2014-02209, NCT02047344
High-Dose Ascorbic Acid in Treating Patients with Stage IIIB-IV Non-small Cell Lung Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201412760, NCI-2015-00709, NCT02420314
Low Calorie Diet in Reducing Side Effects in Patients Undergoing Liver Surgery
Status: Temporarily closed
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: D12052, NCI-2012-01251, NCT01645852
IRX-2 Regimen in Patients With Newly Diagnosed Stage III or IVA Squamous Cell Carcinoma of the Oral Cavity
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: IRX-2 2015-A, NCI-2015-02220, NCT02609386
Noni Extract in Treating Patients with Very Low Risk or Low Risk Prostate Cancer Undergoing Active Surveillance
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: Huang-2015-1, NCI-2016-00082, NCT02648919
Docetaxel with or without Ascorbic Acid in Treating Patients with Metastatic Prostate Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J15106, NCI-2015-01169, IRB00070691, NCT02516670
Cholecalciferol in Treating Patients with Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia with Vitamin D Deficiency
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 556-15, NCI-2015-01502, NCT02553447
Defined Green Tea Catechin Extract and Erlotinib Hydrochloride in Treating Patients with Premalignant Lesions or Previously Treated Early Stage Squamous Cell Cancer of the Head and Neck
Status: Active
Phase: Phase I
Type: Prevention
Age: 18 and over
Trial IDs: WCI1549-08, NCI-2011-03396, IRB00014010, WCI 1549, NCT01116336
Ketogenic Diet in Treating Patients With Stage III-IV Non-Small Cell Lung Cancer Undergoing Chemoradiation
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201102773, NCI-2012-00327, 02110110, NCT01419587
Gemcitabine Hydrochloride, Ascorbic Acid, and Radiation Therapy in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201310772, NCI-2014-00824, GAX-PAN-I, NCT01852890
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Status: Active
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: CTAP101-CL-1017, NCI-2015-01720, NCT02274623
Start Over